share_log

Travelzoo analyst ratings

Benzinga Analyst Ratings ·  Jul 29, 2022 09:24
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/29/2022 83.82% Barrington Research $12 → $10 Maintains Outperform
04/23/2021 230.88% Noble Capital Markets → $18 Upgrades Market Perform → Outperform
03/26/2021 267.65% Ascendiant Capital → $20 Upgrades Hold → Buy
03/18/2021 Noble Capital Markets Downgrades Outperform → Market Perform
07/24/2020 37.87% Barrington Research → $7.5 Initiates Coverage On → Outperform

Travelzoo Questions & Answers

What is the target price for Travelzoo (TZOO)?

The latest price target for Travelzoo (NASDAQ: TZOO) was reported by Barrington Research on July 29, 2022. The analyst firm set a price target for $10.00 expecting TZOO to rise to within 12 months (a possible 83.82% upside). 1 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Travelzoo (TZOO)?

The latest analyst rating for Travelzoo (NASDAQ: TZOO) was provided by Barrington Research, and Travelzoo maintained their outperform rating.

When is the next analyst rating going to be posted or updated for Travelzoo (TZOO)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Travelzoo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Travelzoo was filed on July 29, 2022 so you should expect the next rating to be made available sometime around July 29, 2023.

Is the Analyst Rating Travelzoo (TZOO) correct?

While ratings are subjective and will change, the latest Travelzoo (TZOO) rating was a maintained with a price target of $12.00 to $10.00. The current price Travelzoo (TZOO) is trading at is $5.44, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment